Market Place
Sourcing Support
Biocytogen Licenses RenNano Antibody Platform To Taisho Pharma
30 Mar 2026 //
BUSINESSWIRE
Biocytogen Clears FDA IND For NEOK Bio`s NEOK002 In Solid Tumors
27 Mar 2026 //
PHARMIWEB
Biocytogen, Moonlight Bio Partner To Advance Cell Therapies
23 Mar 2026 //
PHARMIWEB
Biocytogen Doses 1st Patient in IDE034 Ph 1 Bispecific ADC Trial
27 Feb 2026 //
BUSINESSWIRE
Biocytogen`s STAR IPO: As First `H+A` Global Drug Developer
10 Dec 2025 //
PHARMIWEB
FDA Clears IND for Biocytogen`s IDE034 Bispecific ADC
04 Dec 2025 //
BUSINESSWIRE
Biocytogen & Tubulis Sign Exclusive License for Single Antibody
15 Sep 2025 //
BUSINESSWIRE
Biocytogen Partners with Merck KGaA to Enhance For ADC Solution
03 Sep 2025 //
BUSINESSWIRE
Biocytogen Secures Japan Patent for RenMab Platform
05 Jun 2025 //
BUSINESSWIRE
Biocytogen, TQ Secure China IND for Anti-IGF-1R Antibody NTB003
04 Jun 2025 //
BUSINESSWIRE
SOTIO Advances Colorectal ADC SOT109 With Biocytogen Antibodies
09 Jan 2025 //
BUSINESSWIRE
Biocytogen Licenses Human Antibodies To Sotio For Colorectal ADC
09 Jan 2025 //
BUSINESSWIRE
Biocytogen And Acepodia To Advance Bispecific Antibody, ADCs
07 Jan 2025 //
BUSINESSWIRE
Biocytogen Announces Adcendo ApS Exercises Antibody Option
16 Dec 2024 //
BUSINESSWIRE
IDEAYA Announces IDE034 Nomination for B7H3/PTK7 ADC
11 Nov 2024 //
PR NEWSWIRE
Biocytogen Announces IDEAYA’s Nomination of IDE034 Bispecific ADC
11 Nov 2024 //
BUSINESSWIRE
IDEAYA Announces ADC Program Agreement With Biocytogen
31 Jul 2024 //
PR NEWSWIRE
SOTIO And Biocytogen Partner On Multi-Target Antibodies For ADC Pipeline
16 Jul 2024 //
BUSINESSWIRE
Sotio taps Biocytogen to create bispecific ADCs in $326M deal
16 Jul 2024 //
FIERCE BIOTECH
Biocytogen collaborates with BioCopy for TCR-mimic Antibodies evaluation.
06 May 2024 //
BUSINESSWIRE
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific ADC
25 Mar 2024 //
BUSINESSWIRE
Biocytogen Launches RenBiologics
23 Jan 2024 //
BUSINESSWIRE
Biocytogen Enters into Bispecific ADC Agreement with Radiance
08 Jan 2024 //
BUSINESSWIRE
Biocytogen & CtM Achieve Milestone Progress in Developing a TCR-mimic Antibody
27 Dec 2023 //
BUSINESSWIRE
Biocytogen Enters into Antibody Evaluation, Option and Agreement with Myricx
07 Sep 2023 //
BUSINESSWIRE
Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
05 Jul 2023 //
PR NEWSWIRE
Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics
05 Jul 2023 //
BUSINESSWIRE
Chipscreen bags Chinese rights to Biocytogen`s Keytruda killer
27 Feb 2023 //
FIERCE BIOTECH
Biocytogen Launches RenNano Mouse, a Fully Human Heavy Chain Antibody Platform
05 Jan 2023 //
BUSINESSWIRE
